Breathe easier: mindfulness meets pulmonary rehab in new COPD trial

NCT ID NCT07195838

Recruiting now Symptom relief Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new program called Mindful-Breath for people with chronic obstructive pulmonary disease (COPD). The program combines mindfulness, breathing exercises, and lifestyle coaching through group sessions and chat support. Researchers want to see if it is feasible and acceptable, and whether it helps reduce stress and increase physical activity. Sixty participants will be randomly assigned to either the Mindful-Breath program or a standard education session.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hybrid mindfulness-based pulmonary rehabilitation program
What this could lead to: If successful, this could offer a new, accessible way to help COPD patients manage stress, increase physical activity, and improve well-being.
What could go wrong: This is a small pilot study with only 60 participants, so results may not apply to everyone. It focuses on feasibility, not yet on proving effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease Sedentary Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MINDFULNESS PULMONARY REHABILITATION

Contacts and locations

Locations

School of Nursing, The University of Hong Kong, Hong Kong
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.